Lab Automation In Genomics Market Size (2024 - 2029)

The lab automation in genomics market is experiencing significant growth, driven by advancements in genome sequencing and bioinformatics, which enhance data analytics and reveal critical insights. The market's expansion is supported by the increasing affordability and accessibility of DNA sequencing technologies, fostering the emergence of genetic testing start-ups. Laboratory automation is crucial for improving workflow efficiency and accuracy, with companies developing innovative tools to meet diverse application needs. However, high initial setup costs and economic challenges pose obstacles to market growth, particularly in developing regions where cost-effective solutions are prioritized.

Market Size of Lab Automation In Genomics Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Lab Automation In Genomics Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 2.12 Billion
Market Size (2029) USD 3.81 Billion
CAGR (2024 - 2029) 12.43 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Lab Automation In Genomics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Lab Automation in Genomics Market Analysis

The Lab Automation In Genomics Market size is estimated at USD 2.12 billion in 2024, and is expected to reach USD 3.81 billion by 2029, growing at a CAGR of 12.43% during the forecast period (2024-2029).

There has been a significant improvement in understanding genome sequencing in terms of data analytics advances that reveal unknown correlations, hidden patterns, and other insights, especially when testing data sets on a large scale. This is due to technological advancements and increasing computational capacities driving the market.

  • The development of genomics, which uses the availability of whole DNA sequences for entire organisms, is due to the innovative work of a few genomics giants and the more recent next-generation sequencing technology.
  • The speed, volume, and price of genome sequencing have all dramatically increased because of the development of next-generation sequence technologies. Additionally, hundreds of life science databases and programs that promote scientific study have been made possible because of advancements in bioinformatics. These databases make it simple to search, contrast, and analyze the information that is organized and kept there.
  • Furthermore, significant medical advancements are occurring quickly, mostly due to recent improvements in genomic analysis. DNA sequence analysis clarifies how genetic diversity causes disease and ultimately results in novel treatments. Additionally, laboratory automation has opened space for innovative flexibility, increased throughput, and cost-effective solutions. It allows for quick handling and enables the process to be sped up without worrying about accuracy and dependability. Due to the low cost of genotyping and DNA sequencing, the expansion rate is strong.
  • Genetic testing start-ups have been springing up like daisies due to improvements in DNA sequencing technology that have made it more affordable and widely available. However, the knowledge of whole genomes has made functional genomics viable, particularly interested in gene expression patterns under various situations, making it possible for genome sequencing programs to increase rapidly in breadth and speed. The most important tools, in this case, are microarrays and bioinformatics.
  • Nucleic acid isolation, RNAi screening, CRISPR analysis, PCR, and gene expression analysis are just a few of the genomics applications that use automation. Laboratory automation players/vendors are developing tools to meet these application requirements. For example, Tecan Group's new "Fluent Automation Workstation" platform incorporates a variety of capabilities to simplify day-to-day laboratory automation and increase workflow productivity. During a run, the system reacts dynamically, adjusting based on actual times to maintain continuous optimal throughput, all of which are visible in real-time via an easy-to-understand Gantt chart.
  • The companies are developing new products or incorporating new features in the existing products to meet the needs of the customer. For instance, in May 2023, opentrons, a lab automation solution provider, announced the launch of an Opentrons Flex robot, a liquid-handling lab robot. Flex Robot is compatible with artificial intelligence tools.
  • The cost is the major concern in lab automation in the genomics market. The initial setup cost is high, so several developing countries focus on the adoption of cost-effective lab automation systems such as refurbished lab automation. Also, declining consumer spending on buying new and costly equipment due to increasing interest rates and economic downturns restrict market growth.

Lab Automation in Genomics Industry Segmentation

The use of instrumentation to perform laboratory activities with minimum human involvement is known as lab automation. Lab automation is divided into three stages: pre-analytical, analytical, and post-analytical. Automated processes can be applied to all aspects of the experimental process. The scope of the study focuses on the market analysis of lab automation in genomics across the world, and market sizing encompasses the revenue generated by these products sold by various market players.

The lab automation in genomics market is segmented by equipment (automated liquid handlers, automated plate handlers, robotic arms, automated storage and retrieval systems, and vision systems) and geography (North America, Europe, Asia-Pacific, and the Rest of the World). The market sizes and forecasts are provided in terms of value (USD) for all the above segments.

By Equipment
Automated Liquid Handlers
Automated Plate Handlers
Robotic Arms
Automated Storage and Retrieval Systems (AS/RS)
Vision Systems
By Geography***
North America
Europe
Asia
Latin America
Middle East and Africa
Need A Different Region Or Segment?
Customize Now

Lab Automation In Genomics Market Size Summary

The lab automation in genomics market is experiencing significant growth, driven by advancements in genome sequencing technologies and bioinformatics. These developments have enhanced the speed, volume, and cost-effectiveness of genome sequencing, facilitating the creation of extensive life science databases that support scientific research. The integration of automation in laboratory processes has led to increased throughput, flexibility, and cost-efficiency, addressing challenges such as cross-contamination and manual labor limitations. The market is characterized by the emergence of genetic testing start-ups and the rapid expansion of clinical and pre-clinical trials, particularly in regions like North America, which is home to major pharmaceutical companies and contract research organizations. The demand for precision medicine and the need for efficient sample analysis are further propelling the adoption of automated systems in genomics labs.

The competitive landscape of the lab automation in genomics market is marked by the presence of both small and large players, with key strategies focusing on technological advancements, partnerships, and mergers and acquisitions. Major companies such as Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, and Siemens Healthineers are actively developing and integrating new features into their products to meet customer demands. The market is also witnessing innovations like the introduction of automated liquid handling systems and robotic arms, which enhance sample preparation and high-throughput screening capabilities. Despite the high initial setup costs, the market is poised for growth, supported by the increasing availability of affordable lab automation solutions and the ongoing demand for efficient and accurate genomic analysis.

Explore More

Lab Automation In Genomics Market Size - Table of Contents

  1. 1. MARKET INSIGHTS

    1. 1.1 Market Overview

    2. 1.2 Supply Chain Analysis

    3. 1.3 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.3.1 Bargaining Power of Buyers

      2. 1.3.2 Bargaining Power of Suppliers

      3. 1.3.3 Threat of New Entrants

      4. 1.3.4 Threat of Substitute Products

      5. 1.3.5 Intensity of Competitive Rivalry

    4. 1.4 Assessment of the COVID-19 Impact on the Industry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Equipment

      1. 2.1.1 Automated Liquid Handlers

      2. 2.1.2 Automated Plate Handlers

      3. 2.1.3 Robotic Arms

      4. 2.1.4 Automated Storage and Retrieval Systems (AS/RS)

      5. 2.1.5 Vision Systems

    2. 2.2 By Geography***

      1. 2.2.1 North America

      2. 2.2.2 Europe

      3. 2.2.3 Asia

      4. 2.2.4 Latin America

      5. 2.2.5 Middle East and Africa

Lab Automation In Genomics Market Size FAQs

The Global Lab Automation in Genomics Market size is expected to reach USD 2.12 billion in 2024 and grow at a CAGR of 12.43% to reach USD 3.81 billion by 2029.

In 2024, the Global Lab Automation in Genomics Market size is expected to reach USD 2.12 billion.

Lab Automation in Genomics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)